Attached files
| file | filename |
|---|---|
| EX-32.2 - Novo Integrated Sciences, Inc. | ex32-2.htm |
| EX-31.2 - Novo Integrated Sciences, Inc. | ex31-2.htm |
| EX-31.1 - Novo Integrated Sciences, Inc. | ex31-1.htm |
| 10-Q - Novo Integrated Sciences, Inc. | form10q.htm |
EXHIBIT 32.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S. C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Novo Integrated Sciences, Inc., (the “Company”) on Form 10-Q for the quarter ended May 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher David, President of the Company, certify, pursuant to 18 U.S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: July 24, 2017 | By: | /s/ Christopher David |
| Christopher David | ||
| President (principal executive officer) |